{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:41:10Z","timestamp":1791207670286,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":737,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RC4AR060535"],"award-info":[{"award-number":["RC4AR060535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 AR33625"],"award-info":[{"award-number":["RO1 AR33625"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 AR47981"],"award-info":[{"award-number":["RO1 AR47981"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1038\/mt.2014.140","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T12:21:13Z","timestamp":1409055673000},"page":"1741-1752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Aminoglycosides Restore Full-length Type VII Collagen by Overcoming Premature Termination Codons: Therapeutic Implications for Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"22","author":[{"given":"Jon","family":"Cogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T","family":"Woodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2014.140_bib1","series-title":"Epidermolysis Bullosa: Basic and Clinical Aspects","author":"Lin","year":"1992"},{"key":"10.1038\/mt.2014.140_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00370713","article-title":"Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene","volume":"287","author":"Uitto","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"10.1038\/mt.2014.140_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI115938","article-title":"Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases","volume":"90","author":"Uitto","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2014.140_bib4","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1073\/pnas.88.16.6931","article-title":"Human type VII collagen: cDNA cloning and chromosomal mapping of the gene","volume":"88","author":"Parente","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.140_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1523-1747.ep12365129","article-title":"Type VII collagen, anchoring fibrils, and epidermolysis bullosa","volume":"101","author":"Burgeson","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1083\/jcb.103.4.1577","article-title":"Type VII collagen is a major structural component of anchoring fibrils","volume":"103","author":"Sakai","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2014.140_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1600-0625.2008.00723.x","article-title":"Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa","volume":"17","author":"Dang","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1038\/mt.2014.140_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/humu.21651","article-title":"The COL7A1 mutation database","volume":"33","author":"Wertheim-Tysarowska","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1038\/mt.2014.140_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.clpt.6100012","article-title":"Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy","volume":"81","author":"Zingman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1038\/mt.2014.140_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Barton-Davis","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2014.140_bib11","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm1197-1280","article-title":"Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line","volume":"3","author":"Bedwell","year":"1997","journal-title":"Nat Med"},{"key":"10.1038\/mt.2014.140_bib12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"Linde","year":"2008","journal-title":"Trends Genet"},{"key":"10.1038\/mt.2014.140_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.1023","article-title":"Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations","volume":"49","author":"Wagner","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2014.140_bib14","doi-asserted-by":"crossref","first-page":"19483","DOI":"10.1073\/pnas.1312088110","article-title":"Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons","volume":"110","author":"Kuschal","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.140_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00018-009-0177-1","article-title":"Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors","volume":"67","author":"Nicholson","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1038\/mt.2014.140_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.molmed.2012.09.008","article-title":"Sense from nonsense: therapies for premature stop codon diseases","volume":"18","author":"Bidou","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1038\/mt.2014.140_bib17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng1041","article-title":"Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa","volume":"32","author":"Chen","year":"2002","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2014.140_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/1523-1747.ep12349952","article-title":"Culturing keratinocytes and fibroblasts in a three-dimensional mesh results in epidermal differentiation and formation of a basal lamina-anchoring zone","volume":"100","author":"Contard","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm1063","article-title":"Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa","volume":"10","author":"Woodley","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/mt.2014.140_bib20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1523-1747.2003.12571.x","article-title":"Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone","volume":"121","author":"Woodley","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib21","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ymthe.2004.05.016","article-title":"Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo","volume":"10","author":"Woodley","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.140_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mt.2008.234","article-title":"Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa","volume":"17","author":"Remington","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.140_bib24","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm766","article-title":"Stable nonviral genetic correction of inherited human skin disease","volume":"8","author":"Ortiz-Urda","year":"2002","journal-title":"Nat Med"},{"key":"10.1038\/mt.2014.140_bib25","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/jid.2013.10","article-title":"Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa","volume":"133","author":"Woodley","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib26","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.mt.6300041","article-title":"Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing","volume":"15","author":"Woodley","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.140_bib27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2014.140_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/1523-1747.ep12265460","article-title":"Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique","volume":"84","author":"Tidman","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib29","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2014.140_bib30","first-page":"27","article-title":"Aminoglycoside nephrotoxicity","volume":"17","author":"Swan","year":"1997","journal-title":"Semin Nephrol"},{"key":"10.1038\/mt.2014.140_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000013861","article-title":"Aminoglycoside antibiotics","volume":"5","author":"Forge","year":"2000","journal-title":"Audiol Neurootol"},{"key":"10.1038\/mt.2014.140_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.jid.5700031","article-title":"Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey disease","volume":"126","author":"Kellermayer","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jb\/mvp185","article-title":"Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders","volume":"147","author":"Shiozuka","year":"2010","journal-title":"J Biochem"},{"key":"10.1038\/mt.2014.140_bib34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"10.1038\/mt.2014.140_bib35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/cbic.200900779","article-title":"The future of aminoglycosides: the end or renaissance?","volume":"11","author":"Houghton","year":"2010","journal-title":"Chembiochem"},{"key":"10.1038\/mt.2014.140_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1038\/mt.2014.140_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molmed.2012.09.004","article-title":"Cancer syndromes and therapy by stop-codon readthrough","volume":"18","author":"Bordeira-Carri\u00e7o","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1038\/mt.2014.140_bib38","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1073\/pnas.0711795105","article-title":"PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model","volume":"105","author":"Du","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.140_bib39","doi-asserted-by":"crossref","first-page":"e1001593","DOI":"10.1371\/journal.pbio.1001593","article-title":"A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays","volume":"11","author":"McElroy","year":"2013","journal-title":"PLoS Biol"},{"key":"10.1038\/mt.2014.140_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00109-001-0317-z","article-title":"Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system","volume":"80","author":"Keeling","year":"2002","journal-title":"J Mol Med (Berl)"},{"key":"10.1038\/mt.2014.140_bib41","doi-asserted-by":"crossref","first-page":"e1002608","DOI":"10.1371\/journal.pgen.1002608","article-title":"Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin","volume":"8","author":"Floquet","year":"2012","journal-title":"PLoS Genet"},{"issue":"suppl. 1","key":"10.1038\/mt.2014.140_bib42","doi-asserted-by":"crossref","first-page":"33s","DOI":"10.1111\/1523-1747.ep12540422","article-title":"Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture","volume":"81","author":"Boyce","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/1523-1747.ep12462409","article-title":"Stimulation of thymidine incorporation in keratinocytes by insulin, epidermal growth factor, and placental extract: comparison with cell number to assess growth","volume":"90","author":"O\u2019Keefe","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02634257","article-title":"A method for the isolation and serial propagation of keratinocytes, endothelial cells, and fibroblasts from a single punch biopsy of human skin","volume":"31","author":"Normand","year":"1995","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1038\/mt.2014.140_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcp.1041360118","article-title":"Laminin inhibits human keratinocyte migration","volume":"136","author":"Woodley","year":"1988","journal-title":"J Cell Physiol"},{"key":"10.1038\/mt.2014.140_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/120347549700200105","article-title":"Defined system to assess the in vitro induction of a psoriasis phenotype on normal keratinocytes by fibroblasts from psoritic subjects","volume":"2","author":"Krueger","year":"1997","journal-title":"J Cutan Med Surg"},{"key":"10.1038\/mt.2014.140_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1523-1747.ep12259692","article-title":"Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0\u2009M sodium chloride-separated skin","volume":"82","author":"Gammon","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2014.140_bib48","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1074\/jbc.M108779200","article-title":"The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa","volume":"277","author":"Chen","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616307791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616307791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:24:31Z","timestamp":1738949071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616307791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1525001616307791"],"URL":"https:\/\/doi.org\/10.1038\/mt.2014.140","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aminoglycosides Restore Full-length Type VII Collagen by Overcoming Premature Termination Codons: Therapeutic Implications for Dystrophic Epidermolysis Bullosa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2014.140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}